Trxade Group Inc (OTCMKTS:TRXD) – Analysts at Taglich Brothers issued their Q1 2019 earnings estimates for Trxade Group in a research note issued on Thursday. Taglich Brothers analyst H. Halpern forecasts that the company will post earnings of $0.00 per share for the quarter. Taglich Brothers also issued estimates for Trxade Group’s Q2 2019 earnings at $0.00 EPS, Q3 2019 earnings at $0.01 EPS, Q4 2019 earnings at $0.01 EPS and FY2019 earnings at $0.02 EPS.
TRXD has been the topic of a number of other research reports. ValuEngine raised Trxade Group from a “sell” rating to a “hold” rating in a report on Thursday, January 4th. Zacks Investment Research downgraded Trxade Group from a “buy” rating to a “hold” rating in a report on Friday, January 5th.
Trxade Group stock traded up $0.05 during trading hours on Monday, reaching $0.43. The company’s stock had a trading volume of 400 shares, compared to its average volume of 5,993. The company has a debt-to-equity ratio of -1.29, a quick ratio of 1.15 and a current ratio of 1.15. Trxade Group has a 52 week low of $0.22 and a 52 week high of $1.00.
Trxade Group Company Profile
Trxade Group, Inc (Trxade) designs, develops, owns and operates a business-to-business Web-based marketplace focused on the United States pharmaceutical industry. The Company’s products and services include Trxade.com, InventoryRx.com, Pharmabayonline and RxGuru. Its services are distributed through its online platform.
Receive News & Ratings for Trxade Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trxade Group and related companies with MarketBeat.com's FREE daily email newsletter.